Difference between revisions of "Category:MAP3K20 inhibitors"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "Inhibitors of the protein product of mitogen-activated protein kinase kinase kinase 20 (''MAP3K20''), a.k.a. ''MLK7'', ''MLTK'', ''MRK'', or ''ZAK''. Category:Kinase inhibi...")
 
m (Text replacement - "Category:Serine/threonine kinase inhibitors" to "Category:Serine-threonine kinase inhibitors")
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
 
Inhibitors of the protein product of mitogen-activated protein kinase kinase kinase 20 (''MAP3K20''), a.k.a. ''MLK7'', ''MLTK'', ''MRK'', or ''ZAK''.
 
Inhibitors of the protein product of mitogen-activated protein kinase kinase kinase 20 (''MAP3K20''), a.k.a. ''MLK7'', ''MLTK'', ''MRK'', or ''ZAK''.
  
[[Category:Kinase inhibitors]]
+
[[Category:Serine-threonine kinase inhibitors]]

Latest revision as of 16:11, 24 February 2021

Inhibitors of the protein product of mitogen-activated protein kinase kinase kinase 20 (MAP3K20), a.k.a. MLK7, MLTK, MRK, or ZAK.

Pages in category "MAP3K20 inhibitors"

This category contains only the following page.